This is a Phase 2 study of a study drug called tipifarnib. The main goal of the study is to find out what effect, good and/or bad effects the study drug tipifarnib may have on your tumor. A second goal of the study is to evaluate side effects that might be caused by tipifarnib, which could shrink your cancer but it could cause side effects.